Wellstar/TMI Imaging System Being Utilized in Breast Cancer Study at Duke University Medical Center

• Press Release
• Source: Wellstar International, Inc.
• On 9:50 am EST, Friday November 21, 2008

HOLLAND, OH--(MARKET WIRE)--Nov 21, 2008 -- Wellstar International, Inc. (OTC BB:WLSI.OB - News), a provider of specialized diagnostic software and equipment, announced today that the Department of Radiation Oncology at Duke University Medical Center (DUMC) has disclosed its utilization of the Trillenium Medical Imaging system ("TMI") to validate the system's potential to measure the clinical response rates to novel therapies indicated in recurrent breast cancer patients.

Related Quotes

Symbol	Price	Change
WLSI.OB	0.00	0.00

{"s" : "wlsi.ob","k" : "c10,l10,p20,t10","o" : "","j" : ""}

According to Oana Craciunescu, the medical physicist for this study at DUMC, "The TMI Medical Imaging System has been implemented since the spring of 2007; the study's principal objective is to examine the system's ability to help clinicians decide if patients are responding to treatment. Preliminary observations of the effectiveness of the Wellstar/TMI system are encouraging, although more data needs to still be collected. The number of patients monitored to date under this study has been minimal."

At the annual meeting of the Society for Thermal Medicine earlier this year in Munich, Germany, Dr. Blackwell, the Principal Investigator of the study, and Dr. Oana Craciunescu presented information on this unique study. The DUMC group intends to publish complete results on this imaging study following the completion of the Phase I trial in early 2009.

ABOUT WELLSTAR INTERNATIONAL, INC.:

Wellstar International, Inc., through its wholly owned operating subsidiary Trillenium Medical Imaging, Inc. (TMI), is poised to become a leading diagnostic company in the health care industry. TMI has developed and is marketing fully calibrated and functional, thermal imaging systems that utilize state-of-the-art infrared technologies and proprietary software to accurately and cost-effectively measure physiological changes in the human body. More information on the Company and its unique diagnostic software and product line is available on Wellstar's corporate Website by visiting: www.wellstar.us.

FORWARD-LOOKING STATEMENTS:

This press release contains statements, which may constitute 'forward-looking statements' within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

     CONTACT:
      
     Equiti-trend Advisors LLC
     (800) 953-3350 Toll-Free, U.S. & Canada
     (858) 436-3350 Local or International
     9:30 a.m. to 5:00 p.m. Daily